The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...
Pressure to deploy AI is rising. But flawed data means flawed insights, and leaders are calling for a data strategy overhaul.
It’s not the tech that tanks AI projects — it’s the people and planning. The smartest companies are finally getting both ...
The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.